The therapeutic applications of celery oil seed extract on the plasticizer di(2-ethylhexyl) phthalate toxicity

Toxicology and Industrial Health

Volumn 31, Issue 4, 2015, Pages 355-366

  El Shinnawy, Nashwa A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Apium graveolens (celery oil); di(2 ethylhexyl) phthalate; endothelin 1; obesity; PPAR

Indexed keywords

LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHTHALIC ACID DERIVATIVE; PLASTICIZER; PROTECTIVE AGENT; VEGETABLE OIL; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CELERY OIL SEED EXTRACT; CHOLESTEROL; ENDOTHELIN 1; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL; BLOOD; BODY WEIGHT; CELERY; CHEMISTRY; DRUG EFFECTS; DRUG INTERACTION; GENETICS; LIVER; MALE; METABOLISM; ORGAN SIZE; PLANT SEED; POLYMERASE CHAIN REACTION; RAT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA SYNTHESIS; HOUSEKEEPING GENE; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION; LIVER WEIGHT; NONHUMAN; OBESITY; OXIDATIVE STRESS; POLYMERIZATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APIUM GRAVEOLENS; BODY WEIGHT; DRUG INTERACTIONS; LIPIDS; LIVER; MALE; ORGAN SIZE; PHTHALIC ACIDS; PLANT OILS; PLASTICIZERS; POLYMERASE CHAIN REACTION; PPAR ALPHA; PROTECTIVE AGENTS; RATS; SEEDS;

APIUM GRAVEOLENS; APIUM GRAVEOLENS VAR. DULCE; RATTUS;

EID: 84925853579     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233713475515     Document Type: Article

References (57)

1. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37: 911–917.
2. Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J et al. (2006) Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy Journal of Clinical Oncology 24(24): 3979–3983.
3. Chevallier A (1998) The Encyclopedia of Medicinal Plants. New York, NY: DK Publishing Inc., p. 61.
4. Currie RA, Bombail V, Oliver JD, Moore DJ, Lim FL, Kimber L et al. (2005) Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicological Sciences 86(2): 453–469.
5. David RM, Moore MR, Finney DC, Guest D (2000) Chronic toxicity of di(2-ethylhexyl)phthalate in rats. Toxicological Sciences 55(2): 433–443.
6. David RM, Moore MR, Finney DC, Guest D (2001) Reversibility of the chronic effects of di(2 ethylhexyl) phthalate. Toxicologic Pathology 29(4): 430–439.
7. Desvergne B, Feige JN, Casals-Casas C (2009) PPAR-mediated activity of phthalates: a link to the obesity epidemic? Molecular and Cellular Endocrinology 304: 43–48.
8. Doumas BT (1975) Colorimetric determination of total protein based on the biuret method. Clinical Chemistry 21: 1159–1166.
9. Doumas BT, Waston WA, Biggs HG (1971) Albumin standards and measurement of serum albumin with bromocresol green. Clinica Chemica Acta 31: 87–89.
10. Dryer RL (1970) In: Tietz NW (ed) Fundamental of Clinical Chemistry. Philadelphia, PA: W.B. Saunders, p. 329.
11. Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E et al. (2006) From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research 45: 120–159.
12. Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E et al. (2010) The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPAR α dependent mechanisms. Environmental Health Perspectives 118: 234–241.
13. Feige JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C et al. (2007) The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. The Journal of Biological Chemistry 282: 19152–19166.
14. Fisher JS (2004) Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dys-genesis syndrome. Reproduction 127(3): 305–315.
15. Flegg HM (1973) Cholesterol-CHOD-PAP enzymatic colorimetric method. Annals of Clinical Biochemistry 10: 79–84.
16. Fotsis T, Pepper MS, Aktas E, Breit S, Raska S, Adlercentz H et al. (1998) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research 58: 2916–2921.
17. Gómez-Guzmán M, Jiménez R, Sánchez M, José-Zarzuelo M, Galindo P, Quintela AM et al. (2012) Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radical Biology and Medicine 52: 70–79.
18. Gonzalez FJ (2002) The peroxisome proliferator-activated receptor a (PPARa): role in hepatocarcinogenesis. Molecular and Cellular Endocrinology 193: 71–79.
19. Goto T, Takahashi N, Hirai S, Kawada T (2010) Various terpenoids derived from herbal and dietary plants function as PPAR modulators and regulate carbohydrate and lipid metabolism. PPAR Research 2010: 1–9.
20. Grün F (2010) Obesogens. Current Opinion in Endocrinology Diabetes and Obesesity 17: 453–459.
21. Grün F, Blumberg B (2007) Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Reviews in Endocrine and Metabolic Disorders 8: 161–171.
22. Guzik TJ, Harrison DG (2006) Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discovery Today 11: 524–533.
23. Halden RU (2010) Plastics and health risks. Annual Reviews of Public Health 31: 179–194.
24. Howarth JA, Price SC, Dobrota M, Kentish PA, Hinton RH (2001) Effects on male rats of di-(2-ethylhexyl) phthalate and di-n-hexylphthalate administered alone or in combination. Toxicology Letters 121: 35–43.
25. Isenberg JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G, Lington AW et al. (2000) Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver. Toxicological Sciences 56(1): 73–85.
26. Isenberg JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G, Lington AW et al. (2001) Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)- and phenobarbital-induced hepatocellular changes in rodents. Toxicological Sciences 64: 192–199.
27. Jain GC, Pareek H, Khajja BS, Jain K, Jhalani S, Agarwal S et al. (2009) Modulation of di-(2-ethylhexyl) phthalate induced hepatic toxicity by Apium graveolens L. seeds extract in rats. African Journal of Biochemistry Research 3(5): 222–225.
28. Kang JS, Morimura K, Toda C, Wanibuchi H, Wei M, Kojima N et al. (2006) Testicular toxicity of DEHP, but not DEHA, is elevated under conditions of thioacetamide-induced liver damage. Reproductive Toxicology 21: 253–259.
29. Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P et al. (2002) NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reproductive Toxicology 16: 529–653.
30. Knight BL, Hebbachi A, Hauton D, Brown AM, Wiggins D, Patel DD et al. (2005) A role for PPAR alpha in the control of SREBP activity and lipid synthesis in the liver. The Biochemical Journal 15: 413–421.
31. Leone A, Longo C, Trosko JE (2012) The chemopreventive role of dietary phytochemicals through gap junctional intercellular communication. Phytochemistry Reviews. Epub ahead of print 23 May 2012. DOI: 10.1007/s11101-012-9235-7.
32. Lind PM, Lind L (2011) Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly. Atherosclerosis 218: 207–213.
33. Migliarini B, Piccinetti CC, Martella A, Maradonna F, Gioacchini G, Carnevali O (2011) Perspectives on endocrine disruptor effects on metabolic sensors. General and Comparative Endocrinology 170: 416–423.
34. Milkowski A, Garg HK, Coughlin JR, Bryan NS (2010) Nutritional epidemiology in the context of nitric oxide biology: a risk-benefit evaluation for dietary nitrite and nitrate. Nitric Oxide 22(2): 110–119.
35. Momin RA, Nair MG (2002) Antioxidant, cyclooxygenase and topoisomerase inhibitory compounds from Apium graveolens Linn seeds. Phytomedicine 9: 312–318.
36. Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Molecular Aspects of Medicine 26: 33–65.
37. Olsen L, Lind L, Lind PM (2012) Associations between circulating levels of bisphenol A and phthalate metabolites and coronary risk in the elderly. Ecotoxicology and Environmental Safety 80: 179–183.
38. Paget GE, Barnes JM (1964) In: Laurence DR, Bacharach AL (eds) Evaluation of Drug Activities in Pharmacometrics. 1st ed. London, UK, New York, NY: Academic Press.
39. Pereira C, VamanRao C (2006) Combined and individual administration of diethyl phthalate and polychlorinated biphenyls and its toxicity in female Wistar rats. Environmental Toxicology and Pharmacology 21: 93–102.
40. Pinar E, Giray B, Kizilgün M, Rachidi W, Hininger-Favier I, Roussel AM et al. (2012) Di (2-ethylhexyl)phthalate-induced renal oxidative stress and selenium status. Toxicology Letters 211: S162–S163.
41. Powanda MC, Rainsford KD (2011) A toxicological investigation of a celery seed extract having anti-inflammatory activity. Inflammopharmacology 19: 227–233.
42. Raffa RB (2005) Analgesic patent applications. Reviews in Analgesia 8(2): 71–84.
43. Reitman S, Frankel SA (1957) Colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology 28: 56–63.
44. Schmitt CA, Dirsch VM (2009) Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 21: 77–91.
45. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxidants and Redox Signaling 10: 1115–1126.
46. Singh A, Handa SS (1995) Hepatoprotective activity of Apium graveolens and Hygrophila auriculata against paracetamol and thioacetamide intoxication in rats. Journal of Ethnopharmacology 49: 119–126.
47. Sniderman AD, Blank D, Zakarian R, Bergeron J, Froehlich J (2003) Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clinical Biochemistry 36(7): 499–504.
48. Sowbhagya HB, Srinivas P, Krishnamurthy N (2010) Effect of enzymes on extraction of volatiles from celery seeds. Food Chemistry 120: 230–234.
49. Stahlhut RW, Wijngaarden EV, Dye TD, Cook S, Swan SH (2007) Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environmental Health Perspectives 115(6): 876–882.
50. Stein EA (1986) In: Tietz NW (ed) Text Book of Clinical Chemistry. Philadelphia, PA: W.B. Saunders, pp. 879–886.
51. Sugiyama S, Shimada N, Miyoshi H, Yamauchi K (2005) Detection of thyroid system-disrupting chemicals using in vitro and in vivo screening assays in Xenopus laevis. Toxicological Sciences 88(2): 367–374.
52. Sultana S, Ahmed S, Jahangir T, Sharma S (2005) Inhibitory effect of celery seeds extract on chemically induced hepatocarcinogenesis: modulation of cell proliferation, metabolism and altered hepatic foci development. Cancer Letters 221: 11–20.
53. Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nature Reviews Drug Discovery 6: 662–680.
54. Tsi D, Tan BKH (2000) The mechanism underlying the hypocholesterolaemic activity of aqueous celery extract, its butanol and aqueous fractions in genetically hypercholesterolaemic RICO rats. Life Sciences 66(8): 755–767.
55. Van Guilder HD, Vrana KE, Freeman WM (2008) Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44: 619–626.
56. Willhite CC (2001) Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: di(2-ethylhexyl)phthalate (DEHP). Toxicology 160: 219–226.
57. Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH et al. (2004) Reduced expression of peroxisome proliferator-activated receptor-α may have an important role in the development of non-alcoholic fatty liver disease. Journal of Gastroenterology and Herpetology 19: 799–804.